… the efficacy and tolerability of HFrEF therapies in these patients is limited. However, more …
included patients with more severe CKD. In this review on medical therapy in patients with …

… Dapagliflozin in patients with heart failure and reduced ejection fraction.  … Effect of oral iron
repletion on exercise capacity in patients with heart failure with reduced ejection fraction and …

… of patients experienced reverse remodeling (as defined by a >10% increase in ejection fraction
… Our findings suggest that with optimal therapy, many patients may experience significant …

… and frequency of hospitalizations in patients with heart failure and reduced ejection fraction
(HFrEF) (… defibrillators and resynchronization therapy have improved patients‘ symptoms and …

… patients with heart failure with reduced ejection fraction (HFrEF) beyond conventional therapy
… Each class was previously studied with different background therapies and the expected …

… activation therapy (BAT) in patients with heart failure with reduced ejection fraction (HFrEF). …
who had a recent history of NYHA functional class III); ejection fraction ≤35%; stable …

… Patients were stratified by EF as reduced EF (EF <40% [HF–reduced EF]), borderline EF (40…
models, we examined trends in therapies and outcomes. Among 110 621 patients, 50% (55 …

… Optimal pharmacologic therapy of heart failure with reduced ejection fraction (HFrEF) is …
of patients with chronic HFrEF either do not receive guideline-directed medical therapy (GDMT) …

… echocardiography in patients with no change in clinical status or therapy has no clear role.
Findings from 2D TTE in patients with HFrEF, aside from reduced ejection fraction, might …

… patients with chronic heart failure (New York Heart Association class II, III, or IV) and an ejection
fraction of … , in addition to guideline-based medical therapy. The primary outcome was a …